Open AccessThree vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents
Author(s) -
Fausto Feres
Publication year - 2013
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2013.282183
Subject(s) - medicine , zotarolimus , surgery , cardiology , stent , drug eluting stent , restenosis
The current recommendation is for at least 12 months of dual antiplatelet therapy after implantation of a drug-eluting stent. However, the optimal duration of dual antiplatelet therapy with specific types of drug-eluting stents remains unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom